Create an account, provide basic information, and schedule your online consultation with a licensed holistic health doctor.
Use our secure telemedicine video platform to discuss your health concerns from the comfort of your home.
After your consultation, your doctor will create a personalized treatment plan based on your needs.
Our care team will explain all the medication options and help you make the right decision for your weight loss goals.
Zepbound functions by blocking a specific pathway in the body known as the ActRII receptor, which plays a role in muscle growth. Blocking this pathway encourages lean muscle preservation and reduces body fat through several mechanisms.
Zepbound is FDA-approved for chronic weight management as well as for adults with a BMI of 30 kg/m2 or greater or obese adults with a BMI of 27 kg/m2 or greater. Adults with cardiovascular diseases, hypertension, and sleep apnea can benefit from Zepbound.
Zepbound may cause tumors in the thyroid, including thyroid cancer. Keep an eye out for any potential signs, such as hoarseness, difficulty swallowing, shortness of breath, or a lump or swelling in the neck. Inform your healthcare professional if you have any of these symptoms.
Check out more safety information here.
Zepbound dosages are made to fit individual health needs and weight loss goals. The medication comes in easy-to-use dosage pens. Each contains a specific dose that is administered subcutaneously (under the skin).
Treatment usually begins with a starting dose. This can be adjusted based on the patient’s response to the medication and any side effects that occur.
A healthcare provider must prescribe Zepbound for adults who are obese or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.
The prescribed dosage and frequency depend on each patient’s specific health needs. Patients should never adjust their dosage without first consulting their healthcare provider.
Healthcare providers may adjust Zepbound dosages depending on the patient’s progress and any side effects experienced. Regular follow-ups help assess the effectiveness of the treatment and ensure any necessary changes to the dosage are made.
Following the prescribed Zepbound dosage is essential for achieving the best results. Skipping doses or making unauthorized changes to the treatment plan can reduce its effectiveness and increase the risk of side effects.
Patients should follow a consistent injection schedule, as irregular use may disrupt the intended outcomes of the weight loss treatment.
In most cases, symptoms decrease as the body adjusts to the medication.
Talk to your healthcare provider. They can adjust your dosage or provide suggestions for symptom relief. Check the safety information and warnings on this page as well.
For severe or persistent side effects, contact your provider immediately. Never ignore symptoms that are worsening or causing distress.
Alcohol may reduce the effectiveness of Zepbound and increase the likelihood of side effects. Patients are advised to limit or avoid alcohol while undergoing treatment with Zepbound.
Zepbound can interact with other medications, which may alter its effects. Patients should inform their healthcare provider about all medications, including supplements, to prevent potential drug interactions.
Zepbound is not recommended during pregnancy. Women of childbearing age should use effective contraception while taking Zepbound and consult their healthcare provider if they plan to become pregnant.
Patients with severe liver disease should avoid using Zepbound, as it may increase the risk of side effects and reduce the body’s ability to clear the drug.
A GLP-1 receptor agonist that helps with weight loss by reducing appetite, slowing digestion, and improving metabolic health.
A higher-dose semaglutide injection approved specifically for weight loss, helping patients achieve significant and sustained results. Approved by the FDA for weight loss.
A dual-acting GLP-1 and GIP receptor agonist that promotes weight loss by suppressing appetite and improving metabolic function.
An injectable medication with tirzepatide that targets diabetes management and significant weight reduction as a secondary benefit.
An injectable medication containing semaglutide, primarily used for diabetes but effective for weight loss by decreasing hunger and calorie intake.
An oral semaglutide tablet that supports weight loss by reducing appetite and calorie intake while managing blood sugar levels. Not FDA-approved for weight loss.
A combination of naltrexone and bupropion that addresses hunger and cravings, offering a dual-action approach to weight management.
Zepbound is an FDA-approved weight loss medication containing tirzepatide.
Zepbound activates GLP-1 and GIP receptors to reduce appetite, slow digestion, and increase feelings of fullness. This dual action helps lower calorie intake and promotes weight loss.
You need a prescription from a licensed healthcare provider to get Zepbound. Book a consultation with us to get started.
Insurance coverage for Zepbound varies by provider and plan. Contact your insurance provider to verify if Zepbound is covered under your plan.
Zepbound is used for weight loss in adults who are obese or overweight with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol.
The cost of Zepbound varies depending on insurance coverage, pharmacy pricing, and location. Without insurance, it can be expensive, but discount programs or savings cards may be available.
Inject Zepbound subcutaneously (under the skin) using the pre-filled injection pen. Follow the instructions provided by your healthcare provider or the medication guide.
Eli Lilly and Company manufactures Zepbound, the same company that produces Mounjaro.
Inject Zepbound under the skin of the abdomen, thigh, or upper arm. Rotate injection sites each time to avoid irritation.
Use Zepbound once a week at the same time each week. Follow your healthcare provider’s instructions for dosage and injection technique.
Weight loss varies, but clinical studies have shown patients can lose up to 20% of their body weight over several months with consistent use and proper lifestyle changes. **Contact a licensed provider for evaluation.**
The starting dose is typically low and gradually increases over time to reduce side effects. Your healthcare provider will determine the right dose for your weight loss goals.
Zepbound reduces appetite, increases feelings of fullness, and slows digestion, which helps you eat less and lose weight.
Most side effects, such as nausea or diarrhea, are temporary and improve as your body adjusts. If side effects persist, contact your healthcare provider.
Some patients may notice appetite suppression and reduced food intake within the first week. Significant weight loss typically occurs over several months of consistent use.
Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, and decreased appetite. These side effects usually lessen as the body adjusts.
With insurance, Zepbound’s cost varies depending on your coverage and copay. Check with your insurance provider for specific pricing details.
Appetite suppression may begin within the first week, but noticeable weight loss typically occurs after several weeks of consistent use.
Both Mounjaro and Zepbound contain Tirzepatide, but they have different FDA approvals. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight loss.